Aerovate Therapeutics
AVTE
#9171
Rank
โ‚น6.21 B
Marketcap
โ‚น215.11
Share price
0.00%
Change (1 day)
-87.64%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น0.88 Billion

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are โ‚น0.88 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น0.70 B223.07%
2021-12-31โ‚น0.21 B-83.4%
2020-12-31โ‚น1.32 B158.78%
2019-12-31โ‚น0.51 B